HCV in a group of chronic hemodialysis patients.
Since HCV appears to be the major cause of post-transfusion non-A, non-B hepatitis in Italy, this study determines the presence of anti-HCV in a risk group. Among 26 patients, 9 were anti-HCV in a risk group. Among 26 patients, 9 were anti-HCV positive with the ELISA test and all of them were confirmed with the RIBA test of 2nd generation. Only 1 had a poussés movement of ALT levels. Hemodialyzed patients are reactive for HCV probably for the transfusional therapy.
Scipioni
F
F
Transfusion Service, Renzetti Hospital, Lanciano, Italy.
Di Filippo
L
L
Maccarone
M
M
Viola
D
D
Ruzzi
L
L
Terlizzi
R
R
D000328:Adult; D000368:Aged; D005260:Female; D016174:Hepacivirus / Q000276:immunology; D006508:Hepatitis Antibodies / Q000097:blood; D006526:Hepatitis C / Q000209:etiology* / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*
D006508:Hepatitis Antibodies